The move to a virtual meeting platform is not the only thing new about the 2020 San Antonio Breast Cancer Symposium. Alongside all of the cutting-edge educational programming, late-breaking science and networking opportunities you’ve come to expect, day one of this year’s Symposium includes a number of exciting and timely new offerings you won’t want to miss. Check the online program or mobile app for the most up-to-date Symposium schedule.
Tuesday, December 8
8:15 am – 11:00 am
SPECIAL SESSION: Setting the Stage for Health Equity, Collaboration and Partnership
Presented by Tigerlily Foundation & AACR
- Socio-Economic Access Matters
- Not a One Size Fits All: Personalized Medicine for the Underserved
- Policy Change to End Disparities
SPECIAL SESSION: Breast Cancer Care During COVID-19: How Did Patients and Clinicians Respond – A Global Perspective
- Confronting Inequities of Care
- Living With Breast Cancer and COVID-19
- Global Perspectives on Breast Cancer Care During the COVID-19 Pandemic and How BC was Managed and Lessons Learned
9:30 am – 11:00 am
FDA and Breast Cancer Workshop
- Sacituzumab
Christy Osgood, MD, US Food and Drug Administration
- Trastuzumab Deruxtecan
Preeti Narayan, MD, US Food and Drug Administration
- Tucatinib
Mirat Shah, MD, US Food and Drug Administration
Global Breast Cancer Screening
- Breast cancer screening trials in low and middle income countries: Lessons learned
Rengaswamy Sankaranarayanan, MD, MBBS
- Weighing the benefits and harms of breast cancer screening
Philippe Autier, MD, MPH, PhD
